Two major health systems won’t administer controversial new Alzheimer’s drug Jul 15, 2021 (HealthDay)—Two major U.S. health systems say they will not administer the controversial new Alzheimer’s drug Aduhelm. Post navigation Previous Previous post: Machine-learning algorithms used to detect Alzheimer’s during phone conversationsNext Next post: Warm technology puts people with dementia center stage
